NCT02724501View on ClinicalTrials.gov

Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Endometrial Neoplasms
Interventions
BEHAVIORAL

questionnaire

Using questionnaire to obtain patient's medical and family history of cancer.

PROCEDURE

Blood sample-DNA testing / Tumour-genetic markers

Using Samples obtained to produce summary statistics on the tumour markers

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Cancer Trials Group

NETWORK

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT02724501 - Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer | Biotech Hunter | Biotech Hunter